Harnessing the power of microbial genomics for market authorisation of bioinputs.

 

                                                           Contact us for any further information

Download the catalogue

 

 

 

In the face of today’s sustainable development challenges and the growing demand to consume more natural and healthy products, the agricultural inputs industry is increasingly focusing on biointrants such as biofertiliser and biocontrol products. These biological solutions enhance soil fertility, improve plant health, and increase crop yields, while minimising adverse environmental impacts compared to more conventional chemical inputs.

 

 

Bioinputs are composed of either microorganisms as active substance, or theirby-products. In France, all microorganisms must undergo a rigorous safety evaluation process conducted by the Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (ANSES). Applicants are required to compile a dossier substantiating the safety of their product and submit it to ANSES for approval.

By leveraging the power of natural organisms and processes, bioinputs support biodiversity, soil health, and long-term agricultural productivity.They are a vital component of modern, sustainable agriculture, driving progress towards a more resilient and environmentally friendly agricultural future.

 

 

Challenges of ANSES Market Authorisation

Navigating the ANSES safety evaluation process presents significant challenges. The procedure is extensive and complex due to the volume of analyses required and the rigorous expectations. Applicants must meticulously compile and present comprehensive data on the safety of the microorganisms used.

Biofertiliser and biocontrol

This includes detailed scientific evidence, risk assessments, and adherence to strict regulatory standards. The substantial documentation and rigorous scrutiny can be daunting, demanding time, expertise, and resources. Successfully navigating this process is crucial for market approval and ensuring the safety of biofertiliser and biocontrol products.

 

Pricing

Our Offer: Characterisation and effects of the microbial bioinputs

Genomic characterisation of the production strain

• Whole Genome Sequencing (WGS)
  1. Using a hybrid approach combining Long-read and Short-read Sequencing, high-quality sequences are recovered to meet or exceed regulatory bodies expectations (e.g. ANSES).
• Data analysis
  1. De novo assembly is performed on the generated data by a specialised Bioinformatics team, generating a complete and precise genome sequence and enabling detailed characterisation of the production strain.

Search for genes of concern in the production strain

• Toxins factors
  1. The presence of toxins genes is tested by comparing the strain genomic data to various and up-to-date databases. Searches are also conducted in literature to demonstrate the absence of safety concerns in the microorganisms used.

Natural occurrence study in soils

• Metagenomic testing
  1. Using metagenomics, we study the microbiodiversity of soils and give proofs whether the strain occurs naturally or not in soils, as required by the ANSES.

Kinetic study of the strain

• Kinetic study
  1. The strain presence in soil is followed using qPCR from its application to the return to the natural/inherent equilibrium state.

For prokaryotes strains

• Antimicrobial Resistance (AMR) Genes
  1. The presence of AMR genes is tested by comparing the strain genomic data to various and up-to-date databases.

Dossier redaction

• Comprehensive documentation
  1. All the above analyses are delivered in a “ready to publish” format, containing all necessary details on results and analyses.
• Compliance with ANSES guidelines
  1. The dossier follows ANSES guidelines to meet their expectations, providing supporting data in the required format.

 

Advantages of our Offer

Content
Quality and Compliance

Advanced Technology

Utilisation of the most advanced technology available to meet or exceed regulatory bodies expectations.

Rigorous Standards

Adherence to the highest standards of quality and regulatory compliance, ensuring all analyses and documentation align with ANSES guidelines.

Accurate and Reliable Results

Commitment to delivering precise and dependable data, which is critical for the evaluation process.

Proven Success in Regulatory Approvals

Detailed Dossier Preparation

Expertise in compiling comprehensive, ANSES-compliant dossiers that facilitate a smoother approval process.

Comprehensive Services

End-to-End Solutions

Offering a full suite of services from genomic characterisation to dossier preparation, ensuring a seamless and integrated approach to meeting ANSES requirements.

Tailored Support

Customised services to meet the specific needs of each client’s production process and product features.

Avoid Costly Rejections

Navigate regulatory landscape efficiently & effectively

The stringent requirements set by the ANSES and the extensive analyses needed for market authorisation make the process challenging, often resulting in considerable loss of time and money. Partnering with an experienced company like GenoScreen can minimise preventable errors and increase approval success rates.

top-tier genomic expertise

dedicated team

advanced technologies

 

 

Get our catalogue

Fill in the form below

 

Today’s industrial Food production relies on the use of enzymes and additives in order to optimise the production process or to improve the properties of the final product.

  

                                                           Contact us for any further information

 

Download the catalogue

 

 

 

 

These vital components are often derived from microorganisms. Indeed, microorganisms can produce various enzymes through fermentation processes, which can then be isolated and incorporated into processes as catalysts, or into food formulations to improve digestibility and nutrient utilisation by consumers.

Additionally, certain microorganisms themselves, or their by-products, can be directly used as food additives to confer specific health or performance benefits to consumers.

In Europe, these microorganisms can be genetically modified (then called GMM) to be used as improved production microorganisms. Regardless of their origin or modification status, all microorganisms must undergo a rigorous safety and efficacy evaluation process conducted by the European Food Safety Authority (EFSA).

To do so, the applicants are required to compile a dossier substantiating the safety of their product and submit it to the EFSA.

 

 

Challenges of EFSA Safety Evaluation

Navigating the EFSA safety evaluation process presents significant challenges. The procedure is extensive and complex, often creating uncertainty due to the sheer volume of required analyses and stringent prerequisites. Applicants must meticulously compile and present comprehensive data on the safety and efficacy of the microorganisms used.

Food Enzymes & Additives

This includes detailed scientific evidence, risk assessments, and adherence to strict regulatory standards. The extensive documentation and rigorous scrutiny can be daunting, demanding substantial time, expertise, and resources. Successfully navigating this process is crucial for market approval and ensuring the safety and quality of food products.

 

Our offfer

Our Offer: Identity and characterisation of the strain

Genomic characterisation of the production strain

• Whole Genome Sequencing (WGS)
  1. Utilising a hybrid approach that combines Long-read and Short-read Sequencing, high-quality sequences are recovered to meet or exceed EFSA expectations.
• Data analysis
  1. De novo assembly is performed on the generated data by a specialised Bioinformatics team, generating a complete and precise genome sequence and enabling detailed characterisation of the production strain.

Search for genes of concern in the production strain

• Antimicrobial Resistance (AMR) Genes
  1. The presence of AMR genes is tested by comparing the strain genomic data to various and up-to-date databases.
• Virulence factors and toxin
  1. Similarly, searches are conducted both in databases and literature for virulence factors and toxin production genes to demonstrate the absence of safety concerns in the microorganisms used.

Absence of DNA from the production strain in final product

• DNA quantification
  1. Using qPCR, the presence of DNA from the production strain in the feed product is tested and quantified as required by EFSA, to prove its absence.

For Genetically Modified Microorganisms strains

• Sequence comparison
  1. The sequence of the strain of interest is compared with the parental or recipient strain to identify variants.
• Insert stability verification
  1. The stability of the gene of interest insert in the GMM strain is verified through PCR on the inserted region.

For QPS (Qualified Presumption of Safety) strains

• AMR gene determination
  1. Determination of AMR “intrinsic” and “acquired” genes in the production strain by comparing and analysing WGS data.

Dossier redaction

• Comprehensive documentation
  1. All the above analyses are delivered in a “ready to publish” format, containing all necessary results and analyses.
• Compliance with EFSA guidelines
  1. The dossier follows EFSA guidelines to meet their expectations, and data are provided in a standardised format.

 

Ask for a quotation

 

Advantages of our Offer

Content
Quality and Compliance

Rigorous Standards

Adherence to the highest standards of quality and regulatory compliance, ensuring that all analyses and documentation meet EFSA guidelines.

Accurate and Reliable Results

Commitment to delivering precise and dependable data, which is critical for the safety and efficacy evaluation process.

Proven Success in Regulatory Approvals

Successful Track Record

Demonstrated success in helping clients achieve regulatory approvals, highlighting the effectiveness of GenoScreen’s services in navigating the complex EFSA evaluation process.

Detailed Dossier Preparation

Expertise in preparing comprehensive, EFSA-compliant dossiers that facilitate a smoother approval process.

Comprehensive Services

End-to-End Solutions

Offering a full suite of services from genomic characterisation to dossier preparation, ensuring a seamless and integrated approach to meeting EFSA requirements.

Tailored Support

Customised services to meet the specific needs of each client, whether for GMM strains, QPS strains, or standard production strains.

Avoid Costly Rejections

Navigate regulatory landscape efficiently & effectively

During the first semester of 2024, 50% of new Food Additive requests involving microorganisms were rejected by the EFSA, often causing significant time and money losses. Partnering with an experienced company like GenoScreen can minimize preventable errors and increase approval success rates.

top-tier genomic expertise

dedicated team

advanced technologies

 

Get our catalogue

Fill in the form below

With the growing demand for high-quality animal products, the optimisation of feed formulations through the use of additives and enzymes has become a cornerstone of modern industrial feed production practices.

 

 

                                                              Contact us for any further information

 
Download the catalogue

 

 

 

 

 

 

These vital components are often derived from microorganisms. Indeed, microorganisms can produce various enzymes through fermentation processes, which can then be isolated and incorporated into feed formulations to improve digestibility and nutrient utilisation by animals.

Additionally, certain microorganisms themselves, or their by-products, can be directly used as feed additives to confer specific health or performance benefits to animals.

In Europe, these microorganisms can be genetically modified (then called GMM) if necessary. Regardless of their origin or modification status, all microorganisms must undergo a rigorous safety and efficacy evaluation process conducted by the European Food Safety Authority (EFSA).

To do so, the applicants are required to compile a dossier substantiating the safety of their product and submit it to the EFSA.

 

 

Challenges of EFSA Safety Evaluation

Navigating the EFSA safety evaluation process presents significant challenges. The procedure is extensive and complex, often creating uncertainty due to the sheer volume of required analyses and stringent prerequisites. Applicants must meticulously compile and present comprehensive data on the safety and efficacy of the microorganisms used.

Feed Additives & Enzymes

This includes detailed scientific evidence, risk assessments, and adherence to strict regulatory standards. The extensive documentation and rigorous scrutiny can be daunting, demanding substantial time, expertise, and resources. Successfully navigating this process is crucial for market approval and ensuring the safety and quality of feed products.

 

Pricing

Our Offer: Identity and characterisation of the strain

Genomic characterisation of the production strain

• Whole Genome Sequencing (WGS)
  1. Utilising a hybrid approach that combines Long-read and Short-read Sequencing, high-quality sequences are recovered to meet or exceed EFSA expectations.
• Data analysis
  1. De novo assembly is performed on the generated data by a specialised Bioinformatics team, generating a complete and precise genome sequence and enabling detailed characterisation of the production strain.

Search for genes of concern in the production strain

• Antimicrobial Resistance (AMR) Genes
  1. The presence of AMR genes is tested by comparing the strain genomic data to various and up-to-date databases.
• Virulence factors and toxin
  1. Similarly, searches are conducted both in databases and literature for virulence factors and toxin production genes to demonstrate the absence of safety concerns in the microorganisms used.

Absence of DNA from the production strain in final product

• DNA quantification
  1. Using qPCR, the presence of DNA from the production strain in the feed product is tested and quantified as required by EFSA, to prove its absence.

For Genetically Modified Microorganisms strains

• Sequence comparison
  1. The sequence of the strain of interest is compared with the parental or recipient strain to identify variants.
• Insert stability verification
  1. The stability of the gene of interest insert in the GMM strain is verified through PCR on the inserted region.

For QPS (Qualified Presumption of Safety) strains

• AMR gene determination
  1. Determination of AMR “intrinsic” and “acquired” genes in the production strain by comparing and analysing WGS data.

Dossier redaction

• Comprehensive documentation
  1. All the above analyses are delivered in a “ready to publish” format, containing all necessary results and analyses.
• Compliance with EFSA guidelines
  1. The dossier follows EFSA guidelines to meet their expectations, and data are provided in a standardised format.

 

Ask for a quotation

 

Advantages of our Offer

Content
Quality and Compliance

Rigorous Standards

Adherence to the highest standards of quality and regulatory compliance, ensuring that all analyses and documentation meet EFSA guidelines.

Accurate and Reliable Results

Commitment to delivering precise and dependable data, which is critical for the safety and efficacy evaluation process.

Proven Success in Regulatory Approvals

Successful Track Record

Demonstrated success in helping clients achieve regulatory approvals, highlighting the effectiveness of GenoScreen’s services in navigating the complex EFSA evaluation process.

Detailed Dossier Preparation

Expertise in preparing comprehensive, EFSA-compliant dossiers that facilitate a smoother approval process.

Comprehensive Services

End-to-End Solutions

Offering a full suite of services from genomic characterisation to dossier preparation, ensuring a seamless and integrated approach to meeting EFSA requirements.

Tailored Support

Customised services to meet the specific needs of each client, whether for GMM strains, QPS strains, or standard production strains.

Avoid Costly Rejections

Navigate regulatory landscape efficiently & effectively

In 2023, 40% of new feed additive applications involving micro-organisms have been rejected by EFSA. These rejections were due to strain characterization problems, often resulting in considerable loss of time and money. Partnering with an experienced company like GenoScreen can minimize preventable errors and increase approval success rates.

top-tier genomic expertise

dedicated team

advanced technologies

 

Get our catalogue

Fill in the form below

Microbial related products are found everywhere, from the feed given to the animals, to the food, or directly to the biofertilizers used in the soils of our farms. And as safety comes first, in the fields of life sciences and biotechnology, regulatory compliance goes beyond administrative formalities.

 

                                                              Contact us for any further information

 
Download the catalogue

 

 

 

 

 

Regulatory dossiers stands as a cornerstone for ensuring the safety, efficacy, and quality of your products, while also fostering trust among consumers and regulatory authorities alike. In this ever-evolving and intricate landscape, the compilation and submission of regulatory dossiers become pivotal steps in the obtention of market authorizations.

Navigating the regulatory landscape can be daunting, with complexities and nuances that demand meticulous attention to detail. As such, partnering with an expert in the field becomes not just advantageous but essential.

 

Our regulatory offer applies to several cases, listed later, and offers several advantages:

 

Expertise in microbial regulatory services

 

Throughout the years, GenoScreen developed its expertise in regulatory affairs to help its clients and prospects comply with the expectations of the regulatory bodies. We run dossiers compliant testing including genomic characterization of microbial strains and efficacy testing such as impact studies for microbiome related products, and then we analyse the results and compile them in a “ready to publish” format, encompassing all necessary information with utmost transparency about methodology required for regulatory bodies such as EFSA, FDA or ANSES.

 

 

You will be provided with

 

Contact us for any further information

 

 

Feed Additives & Enzymes

For our clients producing thanks to microorganisms Enzymes or Additives for the Feed industries, in order to obtain European market authorisation, they require to go through a Safety (and Efficacy) evaluation process by the European Food Safety Authority (EFSA). We help them by accompanying them in giving proofs of safety and writing in the rightful way their report.

Learn more

Feed Additives & Enzymes

 

Food Enzymes & Additives

 

Food Enzymes & Additives

Food industry uses Enzymes and Additives in their production process. In Europe, these products are under the EFSA regulation to ensure their safety and efficacy. We accompany biotech companies eager to fill in dossiers when it comes to microbiological analyses by providing them EFSA compliant microbiological reports.

  

 

 

Probiotics

Food Industry is increasingly using Probiotics in their food products as we understand further day after day the impact of the microbiomes on health, and the importance to keep healthy microbiomes. We support our clients in their quest of obtaining a market authorisation for their probiotic strains.

Probiotics

  

Biofertiliser & Biocontrol

 

 

Biofertiliser & Biocontrol

We help our clients eager to access the French biofertilizer/biocontrol market to perform analyses as intended by the ANSES authority (Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail). We provide all the expected analyses and prerequisites regarding microbiological safety to our client, to maximise their chances to obtain market authorisation.
 

 

 

Novel Food

Novel Food is officially described by EFSA as “food that had not been consumed to a significant degree by humans in the EU before 15 May 1997”. It needs of course an authorisation before being available for consumption in Europe, once again, it is granted by the EFSA. Our analyses fill all the prerequisites asked for the biological part of the dossier.

Novel Food

 

 

Ask for a quotation 

 

 

Get our catalogue

Fill in the form below

 

Genomics enables the development of a new form of agriculture, adopting a more holistic approach that focuses on the interactions between plants and micro-organisms.

 

                                                              Contact us for any further information

 
Download the catalogue

 

 

 

 

Soils

 

 

Genomics specifically allows us to highlight the interactions that soil bacteria, yeasts and fungi can have with different crops, whether they are annual or perennial.

GenoScreen has established its expertise in this field by contributing, in a pioneering position, in national projects such as BIMM-SOL and GenoSol, which focused on the microbiological quality of soils.

 

GenoScreen’s offer to understand the microbiological component of soils

GenoScreen helps you to identify the microbiological composition of soils, reveal their properties and act on them, either by using inputs or by modifying your farming practices. Our services and solutions include:

Soil study techniques and methods

Our analysis solutions are based on the latest techniques available (Illumina, PacBio and ONT sequencers), and include a wide range of methods:

 

 

 

 

These analyses, along with the conclusions and solutions they provide, require the ability to access repositories of characterised genomic data. Such data repositories can be found in databases of varying degrees of specialisation and documentation. In this regard, our expertise led us to select the best databases and to develop our own, as well as the ability to utilise them effectively.

Soil

 

Ask for a quotation

 

Pricing

The GenoScreen experience in a nutshell...

From setting up your project to delivering the results

Methods and solutions tailored to your projects

Micro-organism studies for over 20 years

Support beyond results delivery

‘materials and methods’ explained

 

Get our catalogue

Fill in the form below

Genomics, and above all metagenomics, constitute the sharpest method for studying interaction between skin and its microbiota, and analysis the entirety of the microorganism communities present on the epidermis.

 

                                                              Contact us for any further information

  
Download the catalogue

 

 

 

   

Our analytical solutions for dermocosmetics

As a true scientific partner, GenoScreen provides the beauty and skin care sector with tailor-made solutions and high-performance tools that boost innovation :

 

 

Skin Microbiota

GenoBiome Skin, our all-in-one offer for analysing cutaneous microorganism communities

Microbiome friendly testing

Metagenomics with several adaptable technologies to shape your own projects : targeted metagenomics 16S (bacteria), 18S/ITS (fungi) in short read and long read, shotgun metagenomics from skin swab samples.

Research and regulatory compliance skin microbiome

 

 

 

Research and regulatory compliance skin microbiome

 

Strain-specific solutions

Genomic tools for identifying, sequencing, annotating and comparing microbial genomes

Genotyping strains of interest (virulence detection)

Bacterial/fungal genes differential expression under varying conditions (with or without application of an active ingredient, for example), using Transcriptomics (RNA-Seq)

Microorganism strains quantification through qPCR approach

 

 

Expertise and know-how

Bioinformatics : customized pipeline developed by GenoScreen, interactive and comprehensive reports

Support from experts : from experimental protocol design to results interpretation, our team of microbiologists will provide you answers to you initial biological questions

Skincare claims validation and Regulatory dossiers fulfillment

Research and regulatory compliance skin microbiome

 

 

Ask for a quotation

 

Examples of GenoScreen involvement in R&D projects for Skin Care

 

 

Pricing

The GenoScreen experience in a nutshell...

From setting up your project to delivering the results

Methods and solutions tailored to your projects

Micro-organism studies for over 20 years

Support beyond results delivery

‘materials and methods’ explained

 

Get our catalogue

Fill in the form below

GenoScreen provides biotech companies with access to high-level, flexible, agile genomics services that match perfectly to their needs in innovative R&D groups.

 

                                                              Contact us for any further information

 
Download the catalogue

 

 

 

 

Research and regulatory compliance skin microbiome

 

Access to cutting-edge genomics facilities

For start-ups, GenoScreen provides guaranteed access to cutting-edge technical facilities that have been designed for research and innovation in genomics.

Our facilities were equipped to address the demands of the pharmaceutical and agrifood sectors, and are structured to deliver irreproachable, high-quality results.

 

Our services cover the full range of needs in genomics and metagenomics :

Pricing

Sanger sequencing & NGS

Targeted sequencing

Genotyping

.

Metagenomic

Meta
transcriptomic

 

 

 

Your partner in innovation

As specialists in innovation, GenoScreen’s scientific staff can get involved in high-level collaborative projects and add their valuable experience to your research efforts. Our organizational structure ensures full confidentiality and the protection of your intellectual property rights.

 

Pricing

The GenoScreen experience in a nutshell...

From setting up your project to delivering the results

Methods and solutions tailored to your projects

Micro-organism studies for over 20 years

Support beyond results delivery

‘materials and methods’ explained

 

Get our catalogue

Fill in the form below